Leukemia & Lymphoma Society (LLS)

Translational Research Program
Mar 01, 2011 Letter of Intent
Mar 15, 2011 Application

http://www.leukemia-lymphoma.org/all_page?item_id=11620

The Translational Research Program was established to encourage and provide support for new and novel clinical research. The goal of the program is to accelerate transfer of findings from the laboratory to clinical application. The program's purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life. A principal intent of the program is to permit the acquisition of sufficient data to apply to an appropriate agency or sponsor for sustained support.

The Translational Research Program (TRP) was developed to encourage and provide early-stage support for clinical research in leukemia, lymphoma and myeloma, which is intended to develop innovative approaches to treatment, diagnosis or prevention.

Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of leukemia, lymphoma and myeloma. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative. The application should have a clear plan for the clinical exploitation of the studies proposed and the results expected. This feature of the proposal will be an important consideration of the review process. While work directed at a further elucidation and understanding of the fundamental cellular and molecular biology of neoplastic lymphohematopoietic cells is a research priority of LLS, the Translational Research Program is specifically intended for the support of work which is clearly clinical in orientation.